MEPACT Trademark

Trademark Overview


On Tuesday, November 30, 2004, a trademark application was filed for MEPACT with the United States Patent and Trademark Office. The USPTO has given the MEPACT trademark a serial number of 78524381. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 22, 2013. This trademark is owned by I.D.M. IMMUNO-DESIGNED MOLECULES. The MEPACT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemicals for use in the manufacture of preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-g lycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy

Preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl- D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-qlycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, and pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia, and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy
mepact

General Information


Serial Number78524381
Word MarkMEPACT
Filing DateTuesday, November 30, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 22, 2013
Registration Number3116184
Registration DateTuesday, July 18, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2006

Trademark Statements


Goods and ServicesChemicals for use in the manufacture of preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-g lycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy
Goods and ServicesPreparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl- D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-qlycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, and pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia, and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 22, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 22, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParis F-75011
FR

Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis F-75011
FR

Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis F-75011
FR

Trademark Events


Event DateEvent Description
Friday, February 22, 2013CANCELLED SEC. 8 (6-YR)
Friday, December 3, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 1, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, October 16, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 16, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 1, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 16, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 18, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2006NOTICE OF PUBLICATION
Thursday, March 2, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 1, 2006ASSIGNED TO LIE
Wednesday, February 8, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 20, 2006AMENDMENT FROM APPLICANT ENTERED
Wednesday, January 4, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 4, 2006PAPER RECEIVED
Wednesday, July 6, 2005NON-FINAL ACTION E-MAILED
Wednesday, July 6, 2005NON-FINAL ACTION WRITTEN
Sunday, July 3, 2005ASSIGNED TO EXAMINER
Thursday, December 30, 2004PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 30, 2004PAPER RECEIVED
Wednesday, December 8, 2004NEW APPLICATION ENTERED IN TRAM